(Q40682721)

22 September 2017

1 reference

title

Drug-induced severe skin reactions. Incidence, management and prevention (English)

1 reference

22 September 2017

P Wolkenstein

1

1 reference

PubMed ID

8527020

22 September 2017

J Revuz

series ordinal

2

1 reference

22 September 2017

1 July 1995

1 reference

22 September 2017

1 reference

22 September 2017

13

1 reference

22 September 2017

56-68

1 reference

22 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199513010-00007

22 September 2017

0 references

cites work

Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: the effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamine

1 reference

12 December 2020

Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids

1 reference

12 December 2020

23 cases of severe bullous dermatitis medicamentosa with epidermolysis

1 reference

12 December 2020

Intestinal involvement in drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

Erythema multiforme: A critical review of characteristics, diagnostic criteria, and causes

1 reference

12 December 2020

The allopurinol hypersensitivity syndrome

1 reference

12 December 2020

Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients

1 reference

12 December 2020

An unusual bullous eruption

1 reference

12 December 2020

Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature.

1 reference

12 December 2020

Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany

1 reference

12 December 2020

Serum sickness-like syndrome associated with minocycline therapy

1 reference

12 December 2020

Toxic epidermal necrolysis. Unmuddying the waters

1 reference

12 December 2020

Phenytoin hepatotoxicity: a case report and review

1 reference

12 December 2020

Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients

1 reference

12 December 2020

Serum sickness-like syndrome associated with propranolol therapy

1 reference

12 December 2020

Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.

1 reference

12 December 2020

Drug-induced febrile mucocutaneous syndrome with a survey of the literature

1 reference

12 December 2020

1 reference

12 December 2020

The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification

1 reference

12 December 2020

Lyell's syndrome in Dakar

1 reference

12 December 2020

Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases

1 reference

12 December 2020

Adverse drug reaction monitoring: doing it the French way

1 reference

12 December 2020

Cutaneous drug reactions: pathogenesis and clinical classification

1 reference

12 December 2020

The staphylococcal scalded-skin syndrome.

1 reference

12 December 2020

[Hematologic anomalies in Lyell's syndrome. Study of 26 cases]

1 reference

12 December 2020

Stevens-Johnson syndrome after mass prophylaxis with sulfadoxine for cholera in Mozambique

1 reference

12 December 2020

Pseudolymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte disregulation

1 reference

12 December 2020

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany

1 reference

12 December 2020

In-vitro assessment of a hypersensitivity syndrome associated with sorbinil

1 reference

12 December 2020

Drug-induced vasculitides

1 reference

12 December 2020

Fifteen cases of toxic epidermal necrolysis (Lyell)

1 reference

12 December 2020

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

1 reference

12 December 2020

Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Sjögren-like syndrome after drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.

1 reference

12 December 2020

Drug hypersensitivity syndrome

1 reference

12 December 2020

Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole

1 reference

12 December 2020

Acute disseminated epidermal necrosis types 1, 2, and 3: study of sixty cases

1 reference

12 December 2020

Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine

1 reference

12 December 2020

HLA antigens in Stevens-Johnson syndrome with ocular involvement.

1 reference

12 December 2020

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

1 reference

12 December 2020

Rheumatology. Side effects of chrysotherapy

1 reference

12 December 2020

Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases

1 reference

12 December 2020

Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement

1 reference

12 December 2020

The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients

1 reference

12 December 2020

Drug-induced toxic epidermal necrolysis treated with cyclosporin.

1 reference

12 December 2020

Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985

1 reference

12 December 2020

Vasculitis and retinoids

1 reference

12 December 2020

Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites

1 reference

12 December 2020

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

1 reference

12 December 2020

Cutaneous drug reactions: clinical types and causative agents. A five-year survey of in-patients (1981-1985).

1 reference

12 December 2020

Suppression of carbamazepine-induced rash with prednisone

1 reference

12 December 2020

[Cutaneous reactions appearing during the mass prophylaxis of cerebrospinal meningitis with a long-delayed action sulfonamide (apropos of 997 cases)]

1 reference

12 December 2020

Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus

1 reference

12 December 2020

Update on the Stevens-Johnson syndrome

1 reference

12 December 2020

A review of toxic epidermal necrolysis in Britain

1 reference

12 December 2020

Bronchopulmonary distress associated with toxic epidermal necrolysis

1 reference

12 December 2020

Hypersensitivity vasculitis due to ofloxacin

1 reference

12 December 2020

Adverse drug reactions: the magnitude of the problem.

1 reference

12 December 2020

Dapsone hypersensitivity. The sulfone syndrome revisited

1 reference

12 December 2020

Serum sickness in children after antibiotic exposure: estimates of occurrence and morbidity in a health maintenance organization population

1 reference

12 December 2020

A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome

1 reference

12 December 2020

Cutaneous side effects associated with interleukin 2 administration for metastatic melanoma

1 reference

12 December 2020

Paraneoplastic pemphigus

1 reference

12 December 2020

Severe Cutaneous Drug Reactions (Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis) in Human Immunodeficiency Virus Infection

1 reference

12 December 2020

Efficacy of cyclophosphamide in toxic epidermal necrolysis. Clinical and pathophysiologic aspects

1 reference

12 December 2020

Cutaneous disease and drug reactions in HIV infection

1 reference

12 December 2020

Genetic susceptibility to toxic epidermal necrolysis

1 reference

12 December 2020

Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982

1 reference

12 December 2020

Cutaneous manifestations of serum sickness in patients receiving antithymocyte globulin

1 reference

12 December 2020

Serum sickness-like illness and leukocytoclastic vasculitis following intracoronary arterial streptokinase

1 reference

12 December 2020

Cutaneous reactions to drugs with special reference to severe bullous mucocutaneous eruptions and sulphonamides

1 reference

12 December 2020

Toxic epidermal necrolysis. A step forward in treatment

1 reference

12 December 2020

Plasmapheresis in severe drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

Observations on drug-induced toxic epidermal necrolysis in Singapore

1 reference

12 December 2020

Toxic epidermal necrolysis: an eruption resembling scalding of the skin

1 reference

12 December 2020

Severe adverse cutaneous reactions to drugs

1 reference

12 December 2020

Acute generalized exanthematous pustulosis. Analysis of 63 cases

1 reference

12 December 2020

10.2165/00002018-199513010-00007

Identifiers

DOI

1 reference

PubMed ID

8527020

Dimensions Publication ID

22 September 2017

0 references

1 reference

PubMed ID

8527020